The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat [editorial] NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat [editorial]

Dis Markers. 1990 May-Jun;8(3):161-2. Unique Identifier : AIDSLINE MED/91106066

Keywords: Comparative Study DNA-Binding Proteins/*METABOLISM DNA, Viral/METABOLISM Gene Expression Regulation, Viral Gene Products, tax/PHYSIOLOGY Genes, Structural Genes, Viral Human *HIV Long Terminal Repeat HIV-1/*GENETICS Lymphocyte Transformation Receptors, Interleukin-2/*GENETICS *Regulatory Sequences, Nucleic Acid T-Lymphocytes/DRUG EFFECTS/IMMUNOLOGY Tetradecanoylphorbol Acetate/PHARMACOLOGY EDITORIAL JOURNAL ARTICLEKWDcomparativestudydna-bindingproteins/KWDmetabolismdna,viral/metabolismgeneexpressionregulation,viralgeneproducts,tax/physiologygenes,structuralgenes,viralhumanKWDhivlongterminalrepeathiv-1/KWDgeneticslymphocytetransformationreceptors,interleukin-2/KWDgeneticsKWDregulatorysequences,nucleicacidt-lymphocytes/drugeffects/immunologytetradecanoylphorbolacetate/pharmacologyeditorialjournalarticle
910530
M9150897

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .